INTERNATIONAL PATENT: GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD., 亘喜生物科技（上海）有限公司 FILES APPLICATION FOR "BISPECIFIC CHIMERIC ANTIGEN RECEPTOR TARGETING CD38 AND CLL1 AND USE THEREOF"

GENEVA, May 26 -- GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. (12th Floor, Building 1, No. 926 Yishan RoadXuhui District, Shanghai 200233), 亘喜生物科技（上海）有限公司 (中国上海市徐汇区宜山路926号1幢12层) filed a patent application (PCT/CN2024/132542) for "BISPECIFIC CHIMERIC ANTIGEN RECEPTOR TARGETING CD38 AND CLL1, AND USE THEREOF" on Nov 18, 2024. With publication no. WO/2025/103498, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which ...